Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Community-acquired pneumonia

P D Brown1, S A Lerner

  • 1Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Lancet (London, England)
|October 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma.

Neuro-oncology·2025
Same author

Distribution of virulence determinants among antimicrobial-resistant and antimicrobial-susceptible <i>Escherichia coli</i> implicated in urinary tract infections.

Indian journal of medical microbiology·2016
Same author

Growth of single-layer boron nitride dome-shaped nanostructures catalysed by iron clusters.

Nanoscale·2016
Same author

Ag-catalysed cutting of multi-walled carbon nanotubes.

Nanotechnology·2016
Same author

Beta Cell Regenerating Potential of <i>Azadirachta indica</i> (Neem) Extract in Diabetic Rats.

The West Indian medical journal·2015
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Community-acquired pneumonia (CAP) management is evolving due to antimicrobial resistance and new pathogen data. Understanding CAP epidemiology and risk factors is crucial for effective treatment, especially in the elderly.

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) is a significant clinical concern, particularly in elderly populations.
  • Understanding CAP epidemiology and microbiology is vital for accurate diagnosis and treatment.
  • Recent data highlight shifts in pathogen incidence, especially atypical pathogens and in severe or elderly cases.

Purpose of the Study:

  • To review the etiology, presentation, diagnosis, and management of CAP in immunocompetent adults.
  • To incorporate new findings on epidemiology, microbiology, and mortality risk factors.
  • To discuss the impact of antimicrobial resistance on empirical CAP therapy.

Main Methods:

  • Review of current literature and guidelines on community-acquired pneumonia.

Related Experiment Videos

  • Analysis of recent epidemiological and microbiological data.
  • Examination of risk factors for CAP mortality and treatment strategies.

    • Main Results:

    • Microbiology of CAP has remained stable, but atypical pathogens are increasingly noted, especially in non-hospitalized patients.
    • New data on risk factors for mortality aid in hospital admission decisions.
    • Antimicrobial resistance in Streptococcus pneumoniae impacts empirical treatment approaches.

    Conclusions:

    • Updated understanding of CAP pathogens and resistance patterns is essential for clinicians.
    • Recent guidelines offer varied approaches to empirical versus pathogen-specific CAP management.
    • Effective CAP management requires integrating new data on risk factors and evolving resistance patterns.